Core Insights - Fourth quarter revenue increased by 17% year over year and 9% sequentially, driven by stabilization in industrial demand and growth in medical and advanced applications [1][20] - Medical sales grew by 21% in 2025, supported by new product introductions and FDA clearance for a next-generation urology system [7][47] - The company made significant progress in expanding its business beyond materials processing applications, with non-materials processing revenue accounting for approximately 14% of total revenue [6][11] Revenue Performance - Materials processing revenue rose by 17% year over year, with stable demand in general industrial applications and increased demand in battery and additive manufacturing [1][20] - Revenue from applications outside of materials processing increased by 15%, driven by higher sales in medical and advanced applications [20] - North America saw a 21% sequential and 23% year-over-year increase in sales, while Europe and Asia also reported growth [21][22] Financial Highlights - Total revenue for the fourth quarter was $274 million, with a GAAP gross margin of 36.1% and adjusted gross margin of 37.6% [20][23] - Operating income was $3 million, with adjusted EBITDA at $41 million, exceeding guidance [25] - The company ended the quarter with $839 million in cash and no debt, supporting ongoing capital allocation strategies [27][28] Strategic Initiatives - The company is focusing on growth in medical, micromachining, and advanced applications, with plans for new product introductions in 2026 [11][12] - The launch of the Crossbow laser defense system marks a significant step in directed energy applications, with strong customer interest reported [9][39] - The Clean Laser acquisition has contributed to revenue synergies and growth in cleaning applications, enhancing the company's competitive position [14][15] Market Outlook - Book-to-bill ratio remains above one, indicating strong order activity and improving market conditions [10][29] - Revenue guidance for Q1 2026 is projected between $235 million and $265 million, with expectations for adjusted gross margin between 37% and 39% [30] - The company remains cautiously optimistic about demand in 2026, while recognizing ongoing macroeconomic uncertainties [10][32]

Financial Data and Key Metrics Changes - Fourth quarter revenue increased by 17% year-over-year and 9% sequentially, driven by stabilization in industrial demand and growth in medical and advanced applications [5][10] - Full-year revenue grew by 3%, marking the first full-year revenue growth since 2021 [6] - GAAP gross margin was 36.1%, while adjusted gross margin was 37.6%, impacted by planned inventory management and tariffs [21][22] - GAAP net income was $13 million or $0.31 per diluted share, with adjusted net income at $20 million, resulting in earnings per diluted share of $0.46 [23] Business Line Data and Key Metrics Changes - Materials processing revenue increased by 17% year-over-year, with stable demand in welding and increased demand in battery and additive manufacturing applications [5][18] - Medical sales grew by 21% year-over-year, driven by new product traction and a major customer win [8][9] - Revenue from applications outside of materials processing increased by 15%, with significant growth in medical and advanced applications [18] Market Data and Key Metrics Changes - North America sales increased by 21% sequentially and 23% year-over-year, driven by higher revenue in cutting, cleaning, medical, and advanced applications [19] - Europe sales increased by 8% sequentially and 7% year-over-year, with strong growth in additive manufacturing and cleaning [19] - Asia revenue improved by 5% sequentially and 19% year-over-year, primarily due to higher welding sales in China [20] Company Strategy and Development Direction - The company is focusing on strengthening its position in core industrial applications while penetrating new non-industrial markets [12] - Growth initiatives in medical, micromachining, and defense are key investment priorities, with expectations for continued momentum into 2026 [11][12] - The company aims to expand its addressable market by integrating laser technology with applications expertise to address complex customer challenges [13] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding improving market conditions and customer demand, despite ongoing macroeconomic uncertainties [10][11] - Strong bookings in Q4 resulted in a book-to-bill ratio above one, indicating positive demand trends [10][26] - The company plans to maintain a balanced capital allocation strategy, investing in growth while returning capital to shareholders [25] Other Important Information - The company received FDA clearance for a next-generation urology system, enhancing its medical product offerings [9] - The cleanLASER acquisition has generated revenue synergies and contributed to growth in the cleaning segment [14][15] - The company has authorized a new $100 million share repurchase program to continue returning capital to shareholders [25] Q&A Session Summary Question: Thoughts on cutting revenue stability and long-term growth targets - Management noted that cutting revenue has stabilized and is expected to grow alongside investments in core markets [32][33] Question: Update on Directed Energy investment and market interest - Management reported strong customer interest in the Crossbow system for military and civilian applications, with plans for future product enhancements [37][38] Question: Margin improvement and revenue levels for fixed cost absorption - Management indicated that revenue levels above $270 million would help improve gross margins, with ongoing cost reduction initiatives in place [40][41] Question: Plans for investment in Directed Energy applications - Management confirmed a roadmap for increasing power levels in Directed Energy products, targeting smaller class drones [45] Question: Expectations for new medical products in 2026 - Management anticipates significant growth in medical sales, with new product launches planned for 2026 [46][47] Question: Competitive environment updates, especially in Asia - Management stated that pricing pressures are minimal in differentiated markets, with strong demand in battery and advanced applications [62] Question: Variability in bookings by region - Management reported broad-based order activity, with North America and Asia showing strong performance, while Europe is improving [68]

Financial Data and Key Metrics Changes - Fourth quarter revenue increased by 17% year-over-year and 9% sequentially, driven by stabilization in industrial demand and growth in medical and advanced applications [5][17] - Full-year revenue grew by 3%, marking the first full-year revenue growth since 2021, with materials processing sales flat and welding revenue stable [6][9] - GAAP gross margin was 36.1%, while adjusted gross margin was 37.6%, impacted by planned inventory management and tariffs [20][22] Business Line Data and Key Metrics Changes - Materials processing revenue increased by 17% year-over-year, with strong performance in welding, marking, cleaning, and additive manufacturing [17] - Medical sales grew by 21% year-over-year, driven by new product traction and a major customer win [7][8] - Revenue from applications outside of materials processing accounted for approximately 14% of total revenue, with double-digit growth in micromachining, medical, and advanced applications [7][10] Market Data and Key Metrics Changes - North America sales increased by 21% sequentially and 23% year-over-year, driven by higher revenue in cutting, cleaning, medical, and advanced applications [18] - Europe saw an 8% sequential and 7% year-over-year increase, primarily from additive manufacturing and cleaning applications [18] - Asia revenue increased by 5% sequentially and 19% year-over-year, with strong demand in battery applications in China [19] Company Strategy and Development Direction - The company is focusing on strengthening its position in core industrial applications while penetrating new non-industrial markets, particularly in medical, micromachining, and directed energy [10][11] - The integration of cleanLASER has provided revenue synergies and enhanced growth in cleaning applications [12][13] - The company aims to capitalize on growth opportunities by combining laser technology with deep applications expertise to address complex customer challenges [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding improving market conditions and customer demand, despite ongoing macroeconomic uncertainties [9][10] - Strong bookings in Q4 resulted in a book-to-bill ratio above one, indicating positive demand trends [9][25] - The company plans to continue investing in growth initiatives while maintaining a strong balance sheet [24][26] Other Important Information - The company received a Prism Award for its new 8-kilowatt single-mode laser, reinforcing its position as a leader in fiber laser innovation [15] - The company is actively looking for tuck-in acquisitions to augment adjacent markets and accelerate growth [48][49] Q&A Session Summary Question: Thoughts on cutting revenue stability and long-term growth targets - Management noted that cutting revenue has stabilized and is expected to grow alongside investments in core markets like additive manufacturing and welding [31][33] Question: Update on Directed Energy opportunities and customer interest - Management reported strong customer interest in the Crossbow system for military and civilian applications, highlighting its differentiation and scalability [35][38] Question: Margin improvement and revenue levels needed for fixed cost absorption - Management indicated that revenue levels above $270 million could help improve gross margins, with ongoing cost reduction initiatives in place [39][40] Question: Plans for investment in Directed Energy applications - Management confirmed plans to increase investment in Directed Energy, with a roadmap for higher power systems in development [44][45] Question: Competitive environment and pricing pressures in Asia - Management stated that pricing remains stable in differentiated areas like battery and additive manufacturing, despite competitive pressures in cutting [60][61] Question: Updates on semiconductor exposure and growth expectations - Management highlighted engagement in lithography, metrology, and inspection, with expectations for growth aligned with semiconductor sector investments [71][72] Question: Clarification on micromachining and additive manufacturing applications - Management explained that additive manufacturing involves sintering powdered metal, while micromachining focuses on precision cutting and drilling for various industries [76][79]

Financial Data and Key Metrics Changes - Second quarter revenue increased by 10% sequentially and 2% year over year, marking the first year-over-year revenue increase since 2022, driven by modest demand improvement across multiple markets [5][18] - Revenue for the quarter was $251 million, with a gross margin of 37.3%, remaining flat year over year [22][23] - Adjusted earnings per diluted share were $0.30, exceeding guidance [24][27] Business Line Data and Key Metrics Changes - Revenue from materials processing decreased by 6% year over year due to divestitures and lower sales in cutting, welding, and additive manufacturing, partially offset by higher revenue in micromachining and the Clean Laser acquisition [18][19] - Medical and advanced applications revenue increased by 21%, driven by higher sales in these segments [18] - Emerging growth products accounted for 54% of sales, indicating strong performance in various laser sources and systems [20] Market Data and Key Metrics Changes - North America sales increased by 31% sequentially but were down 4% year over year, primarily due to higher sales in medical and advanced applications [20] - European sales were stable with less than a 1% sequential decline and down 11% year over year, impacted by lower cutting and welding sales [20] - Asia saw a 4% sequential increase and a 14% year-over-year increase, benefiting from higher sales in welding and cutting, as well as advanced applications [21] Company Strategy and Development Direction - The company is targeting a $5 billion total addressable market (TAM) with strategic initiatives aimed at driving profitable growth [5] - Focus on developing innovative lasers and photonic solutions for medical, micromachining, and advanced applications, with significant progress reported in these areas [9][11] - Capital allocation strategy emphasizes organic growth investments and strategic M&A, with plans to spend approximately $100 million on CapEx in 2025 [12][25] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding demand stabilization, noting improvements in industrial production and inventory normalization among customers [16][46] - The company is adapting to tariff-related challenges by leveraging supply chain flexibility and has successfully mitigated potential delays in customer orders [15][17] - Future guidance anticipates revenue between $225 million and $255 million for 2025, with adjusted gross margins between 36% and 38% [26][27] Other Important Information - The company repurchased $30 million of its stock during the quarter, continuing a trend of returning cash to shareholders [12][25] - The Crossbow laser counter UAV solution has been delivered to Lockheed Martin, showcasing the company's capabilities in directed energy systems [9][10] Q&A Session Summary Question: Can you provide any color on book to bill by region? - Management indicated that the book to bill ratio was approximately one across all regions, which is a positive sign [30][32] Question: How do you view the opportunity for directed energy over the next few years? - Management highlighted the directed energy market as a significant growth area, particularly addressing threats from smaller drones, with ongoing partnerships and extensive testing [34][37] Question: Can you walk us through the Q3 guidance? - Management noted that they were able to ship a significant portion of anticipated orders due to effective tariff mitigation strategies and observed broad-based improvements in demand [42][46] Question: What is the outlook for the systems business? - Management expressed excitement about the Clean Laser acquisition and noted improvements in other systems areas, including micro machining and robotic systems [63][65] Question: How is the competitive environment in the medical business changing? - Management reported strong positioning in the urology market and continued growth with new customer acquisitions [66][68]

Financial Data and Key Metrics Changes - Second quarter revenue increased by 10% sequentially and 2% year over year, marking the first year-over-year revenue increase since 2022, driven by modest demand improvement across multiple markets [5][17] - Revenue came in at $251 million, up 10% sequentially but down 3% year over year, with foreign currency contributing approximately $4 million or 1% to revenue [21][24] - Gross margin was 37.3%, flat year over year, while adjusted gross margin was 37.8%, driven by improved manufacturing cost absorption [21][22] Business Line Data and Key Metrics Changes - Revenue from materials processing decreased by 6% year over year due to divestitures and lower sales in cutting, welding, and additive manufacturing, partially offset by higher revenue in micromachining and the Clean Laser acquisition [17] - Medical and advanced applications revenue increased by 21%, driven by higher sales in these segments [17] - Emerging growth products accounted for 54% of sales, indicating strong performance across various laser sources and systems [18] Market Data and Key Metrics Changes - North America sales increased by 31% sequentially but were down 4% year over year, primarily driven by higher sales in medical and advanced applications [19] - Europe saw stable performance with less than a 1% sequential decline and an 11% year-over-year decrease, while Asia experienced a 4% sequential increase and a 14% year-over-year increase, benefiting from higher sales in welding and cutting [20] Company Strategy and Development Direction - The company is focusing on strategic initiatives targeting a $5 billion total addressable market (TAM) with hundreds of millions in revenue growth opportunities [5] - Continued investment in innovative lasers and photonic solutions is aimed at expanding into medical, micromachining, and advanced applications [8][11] - The capital allocation strategy emphasizes organic growth investments and strategic M&A, with an expected CapEx of approximately $100 million in 2025 [12] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding demand stabilization, noting improvements in industrial production and normalized inventories among cutting OEM customers [15][44] - The company is adapting to the dynamic operating environment by leveraging its global manufacturing supply chain to minimize tariff impacts [14] - Future guidance indicates expected revenue of $225 million to $255 million for 2025, with adjusted gross margin between 36% and 38% [24] Other Important Information - The company repurchased $30 million of its stock during the quarter, building on $1 billion in share repurchases over the past three years [12] - The appointment of five key leaders aims to strengthen the organization and support continued global growth [13] Q&A Session Summary Question: Can you provide any color on book to bill by region? - Management indicated that the book to bill ratio was approximately one across all regions, which was a positive sign [28][30] Question: How is the opportunity for directed energy over the next few years? - Management highlighted that directed energy is a growing market, particularly addressing threats from smaller drones, with significant potential in both defense and civilian sectors [31][34] Question: Can you walk us through the Q3 guidance? - Management noted that they were able to ship $10 million of the anticipated $15 million in Q2, and they see broad-based improvement in demand across various applications [39][42] Question: How did the order book look as the quarter progressed? - Management reported a significant improvement in bookings compared to the previous year, with April being a strong month for bookings [58] Question: Can you comment on the systems business and its recent performance? - Management expressed excitement about the Clean Laser acquisition and noted increases in other areas of systems, including micro machining and welding [60][62] Question: What is the competitive environment in the medical business? - Management stated that they have a strong position in the urology market and are continuing to grow their share with new customer acquisitions [64][66]